Early Findings of AI Study at Frimley Health NHS Foundation Trust Show 99.7% Accuracy in Triaging Chest X-rays as Normal

Qure.aiFrimley Health NHS Foundation Trust and Qure.ai have announced the early results of a pilot study using an innovative radiology AI solution to read and differentiate between normal and abnormal chest X-rays (CXRs).

qXR, a CE class IIb MDR cleared solution developed by Qure, was deployed with the hypothesis to categorise normal x-rays - approximately 40% of the caseload from GP and outpatient requests - and augment overall reporting efficiency. The aim of the study was to highlight AI’s potential role in optimising radiology department workflows, to boost efficiency and enhance patient outcomes.

Early results show 99.7% accuracy in triaging CXRs as normal, with the potential to reduce consultant radiologist’s workload by up to 58% by transferring cases to radiographer reporting workload. This could save consultant radiologists up to 2 hours per day, freeing up time to concentrate on specialist and complex imaging reports.

Additionally, the qXR AI identified all cancer cases, including inconspicuous cancer risk nodules that may traditionally remain unnoticed. This heralds the potential of using AI for early detection and treatment of lung cancer.

Dr Amrita Kumar, Consultant Radiologist and AI Clinical Lead at Frimley Health NHS Foundation Trust states, "AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure's qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department."

Darren Stephens, Senior Vice President & Commercial Head UK and Europe of Qure.ai comments, "The ongoing radiologist shortage, now estimated by Royal College of Radiologists to be 40% by 2027, underscores the importance of healthcare AI to help augment the precious human resource that currently exists, and ensure the delivery of the highest standard of patient care into the future. The qXR study at Frimley Health NHS Foundation Trust is testimony to the clinical leadership at the Trust in embracing AI as an opportunity for positive change."

For further information, please visit:
https://qure.ai

About Qure.ai

Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) tools to make healthcare more accessible and affordable to patients around the world in medical imaging & care coordination. Our technology fulfils a pertinent, unmet need in the radiology industry. With the aid of tools like those developed by Qure.ai, which work via a sophisticated set of algorithms that can instantly evaluate scans to prioritize actionable patient cases quickly, radiologists can focus their time and advanced skill sets on the most pressing diagnoses.

Most Popular Now

AI Predictions for Colorectal Cancer: On…

Colorectal cancer (CRC) ranks second in leading causes of cancer-related deaths globally, according to the WHO. For the first time, researchers from Helmholtz Munich and the University of Technology Dresden...

Combining AI Models Improves Breast Canc…

Combining artificial intelligence (AI) systems for short- and long-term breast cancer risk results in an improved cancer risk assessment, according to a study published in Radiology, a journal of the...

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

Healthcare Chatbot: Expand Support with …

The Danish eHealth platform, sundhed.dk, has faced a substantial surge in requests from Danish citizens and has swiftly expanded its support and effectively adapt to the ongoing changes in queries due...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...